Loxo Oncology
Biotechnology ResearchConnecticut, United States11-50 Employees
Loxo Oncology develops oncological drugs for well-defined patient groups, whose cancers share common genetic drivers.
Insights
Strategic Partnerships Loxo Oncology has established key partnerships with companies like Foghorn Therapeutics and Merus, indicating potential collaboration opportunities and a network for business development initiatives.
Leadership Expansion The recent promotion of Jacob Van Naarden to senior VP and CEO demonstrates growth and potential for engaging at higher management levels, presenting a chance for strategic discussions and sales engagements.
Innovative Research Focus Focused on developing CD3-engaging T-cell therapies, Loxo Oncology shows a commitment to cutting-edge research, offering opportunities for partnerships or sales of related products and services.
Investment in Biotech With investments in companies like Merus B.V. and Kumquatbiosciences, Loxo Oncology displays a strong interest in supporting and expanding the biotech sector, suggesting potential sales avenues within this industry.
Public Listing and Growth Going public in 2014, Loxo Oncology has shown significant growth potential, making it an attractive target for sales opportunities related to investments, services, or products that align with its expansion strategies.
Similar companies to Loxo Oncology
Schrödinger
966
$100M$1BPrelude Therapeutics
149$10M$50MDeciphera Pharmaceuticals
413$50M$100MChemoCentryx
55$10M$50MSpringWorks Therapeutics
327$50M$100MRepare Therapeutics
160$10M$50MHarpoon Therapeutics
51$10M$50MNimbus Therapeutics
102$10M$50MRevolution Medicines
501$50M$100MFogPharma
146$10M$50M
Loxo Oncology Tech Stack
Loxo Oncology uses 8 technology products and services including Oracle, Typekit, Microsoft, and more. Explore Loxo Oncology's tech stack below.
- OracleEnterprise
- TypekitFont Scripts
- MicrosoftMiscellaneous
- PWAMiscellaneous
- Open GraphMiscellaneous
- X-XSS-ProtectionSecurity
- Google Tag ManagerTag Management
- FedExTransportation And Fleet Management
Media & News
Loxo Oncology's Email Address Formats
Loxo Oncology uses at least 1 format(s):
| Loxo Oncology Email Formats | Percentage |
| FLast@loxooncology.com | 90% |
| First.Last@loxooncology.com | 5% |
| First@loxooncology.com | 4% |
| Last@loxooncology.com | 1% |
Frequently Asked Questions
Where is Loxo Oncology's headquarters located?
Loxo Oncology's main headquarters is located at One Landmark SquareSuite 1120 Stamford, CT 06901 United States. The company has employees across 2 continents, including North AmericaAsia. What is Loxo Oncology's stock symbol?
Loxo Oncology is a publicly traded company; the company's stock symbol is LOXO. What is Loxo Oncology's official website and social media links?
Loxo Oncology's official website is loxooncology.com and has social profiles on LinkedIn.What is Loxo Oncology's SIC code NAICS code?
Loxo Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Loxo Oncology have currently?
As of November 2024, Loxo Oncology has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include Chief Medical Officer: D. H.Vice President, Commercial Coo: J. S.Business Owner: R. K.. Explore Loxo Oncology's employee directory with LeadIQ.What industry does Loxo Oncology belong to?
Loxo Oncology operates in the Biotechnology Research industry. What technology does Loxo Oncology use?
Loxo Oncology's tech stack includes OracleTypekitMicrosoftPWAOpen GraphX-XSS-ProtectionGoogle Tag ManagerFedEx. What is Loxo Oncology's email format?
Loxo Oncology's email format typically follows the pattern of . Find more Loxo Oncology email formats with LeadIQ. 
Company Overview
- Headquarters
- One Landmark SquareSuite 1120 Stamford, CT 06901 United States
- Website
- loxooncology.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- LOXO
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 11-50
Media & News
Funding & Financials
Funding & Financials
Company Leadership
D. H.Chief Medical Officer
J. S.Vice President, Commercial Coo
R. K.Business Owner- B. P.Associate Vice President Clinical Diagnostics
- G. O.Vice President, Clinical Development
Employee Directory
- I. R.Director, Discovery Program Management And Chief Of Staff - Discovery Leadership Team
- M. A.Vice President, Clinical Development
- P. J.Senior Vice President, Development
- A. C.Director Of Financial Operations
- A. U.Senior Director, Clinical Biomarkers And Diagnostic Development
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
